Simulation in Drug Development: Good Practices: CDDS

Date: Tue, 27 Jul 1999 12:10:39 -0400 From: "Hui C. Ko" <koh@compuserve.com> Subject: Simulation in Drug Development: Good Practices: CDDS Dear Colleague, In February 1999 CDDS sponsored a meeting "Modeling and Simulation of Clinical Trials: Best Practices Workshop" to develop suggestions for good practices in the use of modeling and simulation. A first version of a document describing the outcome of this meeting has been completed: "Simulation in Drug Development: Good Practices" Editors: Holford NHG, Hale M, Ko HC, Steimer J-L, Sheiner LB, Peck CC Contributors: Bonate P, Gillespie WR, Ludden T, Rubin DB, Stanski D It can be obtained from: http://www.dml.georgetown.edu/cdds/SDDGP.html We consider this document to be dynamic and improvable, so we look forward to receiving feedback. Special attention will be given to commentaries that reflect evaluation of the proposed practices after good faith attempts to implement them. Please direct comments to: Nick Holford, Dept Pharmacology & Clinical Pharmacology University of Auckland, Private Bag 92019, Auckland, New Zealand email:n.holford@auckland.ac.nz tel:+64(9)373-7599 x 6730 fax:373-7556 Carl Peck Director Center for Drug Development Science Georgetown University Medical Center tel: 202-687-4332 fax: 202-687-0193